연구
교육
솔루션
로그인
KR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Hepatopancreatobiliary Surgery,
Shenzhen Institute of Translational Medicine
Yong Ni has not added Biography.
If you are Yong Ni and would like to personalize this page please email our Author Liaison for assistance.
MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway.
Hepatobiliary & pancreatic diseases international : HBPD INT Aug, 2018 | Pubmed ID: 30108016
The First affiliated hospital of Shenzhen University, Shenzhen Second People's Hospital
Ying Lu*,1,2,
Zuhui Pu*,3,
Jiao Chen2,
Jing Deng2,
Ying Deng2,4,
Shufang Zhu2,
Chunliang Xu5,
Fuwen Yao1,2,
Zijing Wu1,2,
Yong Ni1,
Yongqiang Zhan1,
Jun Cheng1,
Naiyang Zhan1,
Wenlong Huang6,
Zhiming Cai2,
Rita Bottino7,
Lisha Mou2
1Department of Hepatopancreatobiliary Surgery, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital,
2Shenzhen Xenotransplantation Medical Engineering Research and Development Center, Shenzhen Institute of Translational Medicine, First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital,
3Imaging Department, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital,
4Faculty of Science, University of Waterloo,
5School of Life Science, The Chinese University of Hong Kong,
6General Surgery, The First Affiliated Hospital of Shantou University Medical College,
7Director Islet Programs, Imagine Pharma
개인 정보 보호
이용 약관
정책
연락처
사서에게 추천하기
JoVE 뉴스레터
JoVE Journal
연구 방법 컬렉션
JoVE Encyclopedia of Experiments
아카이브
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
교수 리소스 센터
저자
사서
액세스
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유